IL70406A - Pharmaceutical compositions comprising a 9,10-dihydroergopeptide and a low molecular weight heparin - Google Patents

Pharmaceutical compositions comprising a 9,10-dihydroergopeptide and a low molecular weight heparin

Info

Publication number
IL70406A
IL70406A IL70406A IL7040683A IL70406A IL 70406 A IL70406 A IL 70406A IL 70406 A IL70406 A IL 70406A IL 7040683 A IL7040683 A IL 7040683A IL 70406 A IL70406 A IL 70406A
Authority
IL
Israel
Prior art keywords
dihydroergopeptide
molecular weight
pharmaceutical compositions
low molecular
weight heparin
Prior art date
Application number
IL70406A
Other versions
IL70406A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL70406A0 publication Critical patent/IL70406A0/en
Publication of IL70406A publication Critical patent/IL70406A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
IL70406A 1982-12-10 1983-12-08 Pharmaceutical compositions comprising a 9,10-dihydroergopeptide and a low molecular weight heparin IL70406A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (2)

Publication Number Publication Date
IL70406A0 IL70406A0 (en) 1984-03-30
IL70406A true IL70406A (en) 1988-08-31

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
IL70406A IL70406A (en) 1982-12-10 1983-12-08 Pharmaceutical compositions comprising a 9,10-dihydroergopeptide and a low molecular weight heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (en)
AT (1) AT382514B (en)
AU (1) AU570658B2 (en)
BE (1) BE898356A (en)
CA (1) CA1224416A (en)
CH (1) CH656533A5 (en)
CY (1) CY1509A (en)
DD (1) DD215469B3 (en)
DK (1) DK162475C (en)
FR (1) FR2537435B1 (en)
GB (1) GB2131691B (en)
GR (1) GR79745B (en)
HK (1) HK23290A (en)
HU (1) HU190513B (en)
IE (1) IE56366B1 (en)
IL (1) IL70406A (en)
IT (1) IT1172368B (en)
LU (1) LU85127A1 (en)
NL (1) NL8304221A (en)
NZ (1) NZ206523A (en)
PH (1) PH23451A (en)
PT (1) PT77803B (en)
SE (1) SE468973B (en)
SG (1) SG53989G (en)
ZA (1) ZA839200B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (en) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger CARCINOM THERAPEUTIC
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (en) * 1991-01-30 1994-10-14 Alfa Wassermann Spa PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441142B (en) * 1975-12-04 1985-09-16 Sandoz Ag PROCEDURE FOR PREPARING A THERAPEUTIC PREPARATION WITH ANTITHROMOBOTIC PROPERTIES
DE2554533C3 (en) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Use of dihydroergotamine and heparin
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
DE3020895A1 (en) * 1979-06-12 1980-12-18 Sandoz Ag ERGOPEPTIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE ERGOPEPTIN DERIVATIVES
DE2945636A1 (en) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach STABLE SOLUTIONS OF HYDRATED ERGOTAL CALOIDS OR YOUR SALTS AND HEPARIN OR ITS SALTS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
IE56366B1 (en) 1991-07-03
IE832896L (en) 1984-06-10
SE8306792D0 (en) 1983-12-08
JPS59116222A (en) 1984-07-05
HK23290A (en) 1990-04-06
GR79745B (en) 1984-10-31
PT77803B (en) 1986-04-17
NL8304221A (en) 1984-07-02
JPH0672101B2 (en) 1994-09-14
ZA839200B (en) 1985-07-31
DK565783A (en) 1984-06-11
IT1172368B (en) 1987-06-18
CA1224416A (en) 1987-07-21
LU85127A1 (en) 1984-10-22
HUT34124A (en) 1985-02-28
GB2131691B (en) 1986-12-03
CH656533A5 (en) 1986-07-15
BE898356A (en) 1984-06-04
IL70406A0 (en) 1984-03-30
PT77803A (en) 1984-01-01
FR2537435A1 (en) 1984-06-15
CY1509A (en) 1990-08-03
DK162475C (en) 1992-05-11
HU190513B (en) 1986-09-29
AT382514B (en) 1987-03-10
DD215469A5 (en) 1984-11-14
SE468973B (en) 1993-04-26
DK565783D0 (en) 1983-12-08
IT8349456A0 (en) 1983-12-07
SG53989G (en) 1989-12-29
SE8306792L (en) 1984-06-11
FR2537435B1 (en) 1987-03-20
NZ206523A (en) 1987-04-30
AU570658B2 (en) 1988-03-24
AU2222183A (en) 1984-06-14
PH23451A (en) 1989-08-07
ATA428483A (en) 1986-08-15
GB2131691A (en) 1984-06-27
GB8332653D0 (en) 1984-01-11
DD215469B3 (en) 1988-03-09
DK162475B (en) 1991-11-04

Similar Documents

Publication Publication Date Title
NZ224275A (en) Low molecular weight heparin derivatives; pharmaceutical compositions
IL95278A0 (en) Very high molecular weight polyethylene
IL92518A0 (en) Aminobenzoates,their preparation and pharmaceutical compositions containing them
IL92377A0 (en) Quinuclidines,their preparation and pharmaceutical compositions comprising them
AU566510B2 (en) Pharmaceutical 1,4-benzodiazepine-2-ones
ZA878813B (en) Moisture-curable low molecular weight polymers and compositions and composites thereof
IL100229A0 (en) N,o-sulphated heparosans,their preparation and pharmaceutical compositions containing them
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
IL90864A0 (en) Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them
EP0174551A3 (en) Low molecular weight copolymers and covulcanisates prepared therefrom
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
AU1033183A (en) Low molecular weight heparins
IL72562A (en) 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them
GB2131294B (en) Low molecular weight angiogenic factor
GB8332892D0 (en) Molecular weight controllers combination
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
AU3454984A (en) 1,z-dithiolanes and pharmaceutical compositions
IL70406A (en) Pharmaceutical compositions comprising a 9,10-dihydroergopeptide and a low molecular weight heparin
EP0350166A3 (en) Polymer compositions
PH22848A (en) 3,3-dialkyl- and 3,3,-alkylene-indoline derivatives, pharmaceutical compositions comprising them and their use
IL68831A (en) 2,2-dimethyl-3-aryl-cyclo-butanones and their preparation
IL85254A0 (en) 14,15-substituted lanosterols and pharmaceutical compositions containing them
IL69817A (en) 7-anilinoisoquinoline-5,8-quinones,their preparation and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
RH Patent void